FDA, Reagan-Udall launch end-to-end expanded access program for cancer
FDA's Oncology Center of Excellence and the Reagan-Udall Foundation launched Expanded Access Navigator and Project Facilitate, two separate but coordinated pilot programs to provide patients and physicians with expanded access to oncology drugs. The launches came Monday at the American Society of Clinical Oncology (ASCO) meeting in Chicago.
Expanded Access Navigator from Reagan-Udall provides searchable clinical trials, agents and company expanded access policies. "For the first time, those who need access will find it in one place without having to go site-by-site," said Ellen Sigal, chair of the foundation. She added that the navigator has been a "high priority" for the foundation and that the site walks patients and physicians "step-by-step through investigational drugs."